1. Fecal Microbiota Transplantation Controls Progression of Experimental Autoimmune Hepatitis in Mice by Modulating the TFR/TFH Immune Imbalance and Intestinal Microbiota Composition
   Ma Liang et al, 2021, Frontiers in Immunology CrossRef
2. Repeated Fecal Microbial Transplantations and Antibiotic Pre-Treatment Are Linked to Improved Clinical Response and Remission in Inflammatory Bowel Disease: A Systematic Review and Pooled Proportion Meta-Analysis
   Valentin Mocanu et al, 2021, Journal of Clinical Medicine CrossRef
3. Gut Microbiota as an Emerging Therapeutic Avenue for the Treatment of Nonalcoholic Fatty Liver Disease
   Tanya Ralli et al, 2021, Current Pharmaceutical Design CrossRef
4. Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial
   Jan Březina et al, 2021, Journal of Clinical Medicine CrossRef
5. Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis
   Yapeng Yang et al, 2022, Frontiers in Immunology CrossRef
6. Features of Gut Microbiome Associated With Responses to Fecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review
   Jindong Zhang et al, 2022, Frontiers in Medicine CrossRef
7. The pathogenic role of intestinal flora metabolites in diabetic nephropathy
   En Tian et al, 2023, Frontiers in Physiology CrossRef
8. Gut microbiota could modulate the effects of neuro-immune responses and memory traces via the gut-brain-immune axis in schizophrenia
   Haruka Sawamura et al, 2022, Exploration of Neuroprotective Therapy CrossRef
9. Changes of intestinal microbiota and microbiota-based treatments in IBD
   Qianyu Li et al, 2022, Archives of Microbiology CrossRef
10. Orchestrating the fecal microbiota transplantation: Current technological advancements and potential biomedical application
    Manisha Nigam et al, 2022, Frontiers in Medical Technology CrossRef
11. Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy
    Dagmar Schierová et al, 2020, Cells CrossRef
12. Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation
    Hao-Ming Xu et al, 2021, Frontiers in Microbiology CrossRef
13. Efficacy of probiotics on the modulation of gut microbiota in the treatment of diabetic nephropathy
    Nozomi Nagase et al, 2022, World Journal of Diabetes CrossRef
14. Fecal Microbiota Transplant in Two Ulcerative Colitis Pediatric Cases: Gut Microbiota and Clinical Course Correlations
    Andrea Quagliariello et al, 2020, Microorganisms CrossRef
15. Microbiome First Medicine in Health and Safety
    Rodney R. Dietert, 2021, Biomedicines CrossRef
16. Whole intestinal microbiota transplantation is more effective than fecal microbiota transplantation in reducing the susceptibility of DSS-induced germ-free mice colitis
    Yapeng Yang et al, 2023, Frontiers in Immunology CrossRef
17. The Effectiveness of Multi-Session FMT Treatment in Active Ulcerative Colitis Patients: A Pilot Study
    Dorota Mańkowska-Wierzbicka et al, 2020, Biomedicines CrossRef
18. Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease
    Xiaochen Zhang et al, 2022, Frontiers in Medicine CrossRef
19. Fecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea
    Hong-Li Huang et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
20. Advances and optimization strategies in bacteriophage therapy for treating inflammatory bowel disease
    Yang Li et al, 2024, Frontiers in Immunology CrossRef
21. Impact of cap-assisted colonoscopy during transendoscopic enteral tubing: A randomized controlled trial
    Quan Wen et al, 2020, World Journal of Gastroenterology CrossRef
22. Impacts of Gut Microbiota on the Immune System and Fecal Microbiota Transplantation as a Re-Emerging Therapy for Autoimmune Diseases
    Ashenafi Feyisa Beyi et al, 2022, Antibiotics CrossRef